Post by Isomorphic Labs

Next week, Isomorphic Labs President Max Jaderberg will join Avery Klemmer from Thrive Capital and Michael de la Merced from the The New York Times at SXSW London. Following our recent $2.1B funding announcement, the conversation will explore the critical role long-term investment plays in developing our AI-powered drug design engine (IsoDDE). See the comments for the agenda.